Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
News|Articles|October 5, 2016
B&W Tek Takes Analysis, Testing, and Quality Control Award at CPhI
Author(s)Pharmaceutical Technology Editors
The CPhI Pharma Award for Excellence in Analysis, Testing, and Quality Control went to B&W Tek for its handheld laser induced breakdown spectroscopy (LIBS) analyzer, NanoLIBS, which has been developed for rapid identification of solid materials based on elemental analysis. The instrument features a raster scan using a high repetition rate class 3B laser allowing for detection of elements including C, Li, and Be.
The CPhI Pharma Award for Excellence in Analysis, Testing, and Quality Control went to B&W Tek for its handheld laser induced breakdown spectroscopy (LIBS) analyzer, NanoLIBS, which has been developed for rapid identification of solid materials based on elemental analysis. The instrument features a raster scan using a high repetition rate class 3B laser allowing for detection of elements including C, Li, and Be.
When a batch of salts is received, a sample less than a gram can be quickly taken in the receiving area and pressed into a tablet form on the spot. With the tableted salt, the NanoLIBS takes only seconds to give an identification result of the salt based on the elemental composition to notify the user whether the sampled drum is what it is supposed to be.
The NanoLIBS is lightweight with touch screen operation for rapid material identification using identification and investigation operation modes, giving results in seconds. The NanoLIBS features a high-brightness touchscreen and an intuitive workflow with its 21CFR Pt 11 compliant software, which provides rapid pass/fail results for material verification. Results are clearly displayed and can be reviewed on the easy-to-use touchscreen interface. User-defined libraries are easily generated for the rapid identification of unknowns with a Match/No Match result.
The NanoLIBS allows companies to quickly implement a ready solution for raw material salt identification that is easy to use and understand. Data from the device can be transferred via Wi-Fi or Ethernet to a computer to generate reports that provide traceability. The NanoLIBS gives pharmaceutical companies the complementary technology that they need to save time in analysis and significantly decrease down-time where raw materials are tied up in quarantine as they are tested.
Related to this article
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.